Biopsin Pte.
Latest round
- Seed
Last raised
- May 2022
Total raised
- $0.5M
Investors
- 3
About Biopsin Pte.
Biopsin Pte. Ltd.Founded in 2018, Biopsin Pte. Ltd. operates from Singapore and is dedicated to creating diagnostic solutions for healthcare., and Entrepreneur First.672 mn.Biopsin specializes in developing innovative diagnostic tools aimed at enhancing disease detection and management. Their core product offerings include advanced biomarker assays and diagnostic kits designed for use in clinical laboratories and healthcare settings. These products leverage proprietary technologies to analyze biological samples, providing healthcare professionals with critical insights into patient conditions, thereby aiding in timely interventions. The primary end users of Biopsin’s products comprise hospitals, diagnostic laboratories, and research institutions, who utilize these assays to diagnose various diseases, including cancer and autoimmune disorders.Biopsin generates revenue primarily through direct sales of its diagnostic products and strategic partnerships with healthcare providers and laboratories. The company’s transaction structure typically involves B2B relationships, where clients purchase diagnostic kits on a contract basis, allowing for a consistent supply to meet demand within clinical settings. Pricing plans for these products are crafted to accommodate the diverse needs of their client base, which may include bulk purchase agreements for larger healthcare institutions. Biopsin's flagship products are integral to the diagnostic workflows in laboratories, further solidifying the company’s role as a key player in the medical diagnostics industry.Biopsin Pte. Ltd. The company is focused on developing additional diagnostic tools aimed at improving disease management, with plans for new product launches expected in the near future. Furthermore, Biopsin aims to target expansion into emerging markets in Asia and Europe by 2024, ensuring a broader reach for its innovative solutions.
Who invested in Biopsin Pte.
3 investors across 1 round
See all investors in Biopsin Pte.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 31, 2022
Amount
$0.5M
Investors
Questions about Biopsin Pte.
Who invested in Biopsin Pte.?
Biopsin Pte. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biopsin Pte. raised?
Biopsin Pte. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Biopsin Pte. last raise money?
Biopsin Pte.'s most recent round on record is a Seed, in May 2022.
What does Biopsin Pte. do?
Biopsin Pte. is a biotechnology company.
Where is Biopsin Pte. headquartered?
Biopsin Pte. is headquartered in Singapore, Singapore.
Which VCs invest in companies like Biopsin Pte.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Biopsin Pte.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Biopsin Pte.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.